I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced R..:
Batoul Dia
;
Sahar Alkhansa
;
Rachel Njeim
...
https://www.mdpi.com/1999-4923/15/3/965. , 2023
Link:
https://doi.org/10.3390/pharmaceutics15030965
RT Journal T1
SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d293c3e23089461c8b54c49f5382677e&Exemplar=1&LAN=DE A1 Batoul Dia A1 Sahar Alkhansa A1 Rachel Njeim A1 Sarah Al Moussawi A1 Theresa Farhat A1 Antony Haddad A1 Mansour E. Riachi A1 Rashad Nawfal A1 William S. Azar A1 Assaad A. Eid PB MDPI AG YR 2023 K1 diabetic kidney disease K1 SGLT2 inhibitor K1 20-HETE K1 oxidative stress K1 inflammatory markers K1 Pharmacy and materia medica K1 RS1-441 JF https://www.mdpi.com/1999-4923/15/3/965 LK http://dx.doi.org/https://doi.org/10.3390/pharmaceutics15030965 DO https://doi.org/10.3390/pharmaceutics15030965 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)